Welcome to LookChem.com Sign In|Join Free
  • or
3-METHYLURACIL is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

608-34-4

Post Buying Request

608-34-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

608-34-4 Usage

Definition

ChEBI: A pyrimidone that is uracil with a methyl group at position 3.

Synthesis Reference(s)

Journal of Heterocyclic Chemistry, 18, p. 339, 1981 DOI: 10.1002/jhet.5570180222Tetrahedron, 39, p. 3919, 1983 DOI: 10.1016/S0040-4020(01)90895-6

Check Digit Verification of cas no

The CAS Registry Mumber 608-34-4 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 6,0 and 8 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 608-34:
(5*6)+(4*0)+(3*8)+(2*3)+(1*4)=64
64 % 10 = 4
So 608-34-4 is a valid CAS Registry Number.
InChI:InChI=1/C5H6N2O2/c1-7-4(8)2-3-6-5(7)9/h2-3H,1H3,(H,6,9)

608-34-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-methyluracil

1.2 Other means of identification

Product number -
Other names 2,4-Dihydroxy-3-methylpyrimidine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:608-34-4 SDS

608-34-4Synthetic route

2-methoxy-3-methylpyrimidin-4(3H)-one
27460-04-4

2-methoxy-3-methylpyrimidin-4(3H)-one

3-methyluracil
608-34-4

3-methyluracil

Conditions
ConditionsYield
With hydrogenchloride In 1,4-dioxane at 60℃; for 2h; Hydrolysis;98%
5-bromo-3-methyl-2,4(1H,3H)pyrimidinedione
6832-03-7

5-bromo-3-methyl-2,4(1H,3H)pyrimidinedione

3-methyluracil
608-34-4

3-methyluracil

Conditions
ConditionsYield
With N-methylphenothiazine at 170℃; for 0.5h;87%
With sodium dithionite; sodium carbonate In water; acetonitrile for 1h; Ambient temperature;85.6%
With Me2SiI In acetonitrile at 20℃; for 2h;7%
orthoformic acid triethyl ester
122-51-0

orthoformic acid triethyl ester

N-Methylurea
598-50-5

N-Methylurea

Polymer: 4-phenylbutan-2-one cyclic malonic acid ester, bound to Merrifield resin

Polymer: 4-phenylbutan-2-one cyclic malonic acid ester, bound to Merrifield resin

3-methyluracil
608-34-4

3-methyluracil

Conditions
ConditionsYield
Stage #1: orthoformic acid triethyl ester; Polymer: 4-phenylbutan-2-one cyclic malonic acid ester, bound to Merrifield resin for 6h; Heating;
Stage #2: N-Methylurea for 12h; Heating;
Stage #3: at 220 - 240℃; for 0.333333h; Further stages.;
82%
(3-methyl-uracil-4-ylidene)W(CO)5

(3-methyl-uracil-4-ylidene)W(CO)5

3-methyluracil
608-34-4

3-methyluracil

Conditions
ConditionsYield
With tert.-butylhydroperoxide In 1,2-dichloro-ethane at 70℃; for 8h;80%
3-methyl-2,3-dihydro-2-thioxo-pyrimidin-4(1H)-one
576-28-3

3-methyl-2,3-dihydro-2-thioxo-pyrimidin-4(1H)-one

A

3-methylpyrimidin-4-one
6104-45-6

3-methylpyrimidin-4-one

B

3-methyluracil
608-34-4

3-methyluracil

C

SO2, H2SO4

SO2, H2SO4

Conditions
ConditionsYield
With oxygen; ozone In acetic acid for 0.1h; Ambient temperature;A 72%
B 25%
C n/a
3-methyl-5,8-methano-3,4,r-4a,c-5,c-8,c-8a-hexahydroquinazoline-2,4-dione
113094-27-2

3-methyl-5,8-methano-3,4,r-4a,c-5,c-8,c-8a-hexahydroquinazoline-2,4-dione

3-methyluracil
608-34-4

3-methyluracil

Conditions
ConditionsYield
for 0.166667h; Heating;65%
3-methylpyrimidin-4-one
6104-45-6

3-methylpyrimidin-4-one

3-methyluracil
608-34-4

3-methyluracil

Conditions
ConditionsYield
With oxygen; aldehyde oxidase In water at 25℃; Kinetics; Mechanism; Product distribution; pH optimum;64%
Rabbit liver aldehyde oxidase immobilized onto DEAE Sepharose CL 6B at 4℃; 10 mM potassium phosphate buffer, pH 7.5, 0.1 mM EDTA;64 % Spectr.
1-methylindole
603-76-9

1-methylindole

5-bromo-3-methyl-2,4(1H,3H)pyrimidinedione
6832-03-7

5-bromo-3-methyl-2,4(1H,3H)pyrimidinedione

A

3-methyluracil
608-34-4

3-methyluracil

B

3-methyl-6-(1-methylindol-3-yl)uracil
89246-31-1

3-methyl-6-(1-methylindol-3-yl)uracil

C

3-methyl-5-(1-methylindol-3-yl)uracil
89246-32-2

3-methyl-5-(1-methylindol-3-yl)uracil

Conditions
ConditionsYield
at 170℃; for 0.5h;A 55%
B 9%
C 18%
5-bromo-3-methyl-2,4(1H,3H)pyrimidinedione
6832-03-7

5-bromo-3-methyl-2,4(1H,3H)pyrimidinedione

1-Benzyl-1,4-dihydronicotinamide
952-92-1

1-Benzyl-1,4-dihydronicotinamide

A

3-methyluracil
608-34-4

3-methyluracil

B

1-benzyl-3-methyl-2,4-pyrimidinedione
61686-79-1

1-benzyl-3-methyl-2,4-pyrimidinedione

C

5-benzyl-3-methyluracil
61686-78-0

5-benzyl-3-methyluracil

Conditions
ConditionsYield
at 180℃; for 3h; Product distribution; Mechanism; examination of further 5-bromouracils, reducing compounds, solvent, temperature and reaction time;A 54%
B 9.7%
C 19.4%
at 180℃; for 3h;A 54%
B 9.7%
C 19.4%
5-bromo-3-methyl-2,4(1H,3H)pyrimidinedione
6832-03-7

5-bromo-3-methyl-2,4(1H,3H)pyrimidinedione

N,N-dimethyl acetamide
127-19-5

N,N-dimethyl acetamide

A

3-methyluracil
608-34-4

3-methyluracil

B

5,5'-methylenebis(3-methyluracil)
81078-01-5

5,5'-methylenebis(3-methyluracil)

Conditions
ConditionsYield
at 180℃; for 6h;A 50.4%
B 37%
5-bromo-3-methyl-2,4(1H,3H)pyrimidinedione
6832-03-7

5-bromo-3-methyl-2,4(1H,3H)pyrimidinedione

A

3-methyluracil
608-34-4

3-methyluracil

B

5,5'-methylenebis(3-methyluracil)
81078-01-5

5,5'-methylenebis(3-methyluracil)

Conditions
ConditionsYield
With N,N-dimethyl acetamide at 180℃; for 6h;A 50.4%
B 37%
2,2-dimethyl-4H-1,3-dioxin-4-one
87769-48-0

2,2-dimethyl-4H-1,3-dioxin-4-one

N-Methylurea
598-50-5

N-Methylurea

A

1-methyluracil
615-77-0

1-methyluracil

B

3-methyluracil
608-34-4

3-methyluracil

Conditions
ConditionsYield
In N,N-dimethyl-formamide; toluene for 0.166667h; Heating;A 39%
B 32%
uracil
66-22-8

uracil

dimethyl sulfate
77-78-1

dimethyl sulfate

A

1-methyluracil
615-77-0

1-methyluracil

B

3-methyluracil
608-34-4

3-methyluracil

C

1,3-dimethyluracil
874-14-6

1,3-dimethyluracil

Conditions
ConditionsYield
Stage #1: uracil With lithium hydride In N,N-dimethyl-formamide at 60℃; for 0.5h;
Stage #2: dimethyl sulfate In N,N-dimethyl-formamide at 60℃; for 72h;
A 30%
B 5%
C 12%
trimethyl phosphite
512-56-1

trimethyl phosphite

Cytosine
71-30-7

Cytosine

A

3-methylcytosine
4776-08-3

3-methylcytosine

B

3-methyluracil
608-34-4

3-methyluracil

C

1-MeCyt
1122-47-0

1-MeCyt

D

1,3-dimethylcytosine
6749-87-7

1,3-dimethylcytosine

Conditions
ConditionsYield
In ethanol at 80℃; for 31h;A 20%
B 10%
C 4%
D 11%
2'-deoxy-3-N-methyl-3',5'-di-O-methyl-2'-methyleneuridine
1174638-88-0

2'-deoxy-3-N-methyl-3',5'-di-O-methyl-2'-methyleneuridine

trimethylsilyl-2,2-difluoro-2-(fluorosulphonyl)acetate
120801-75-4

trimethylsilyl-2,2-difluoro-2-(fluorosulphonyl)acetate

A

3-methyluracil
608-34-4

3-methyluracil

B

2-O-difluoromethyl-3-N-methyluracil
1174638-90-4

2-O-difluoromethyl-3-N-methyluracil

Conditions
ConditionsYield
Stage #1: 2'-deoxy-3-N-methyl-3',5'-di-O-methyl-2'-methyleneuridine With sodium fluoride In toluene at 110℃; for 0.5h; Inert atmosphere;
Stage #2: trimethylsilyl-2,2-difluoro-2-(fluorosulphonyl)acetate In toluene Reflux; Inert atmosphere;
A 11%
B 17%
2-methylthio-3-methylpyrimidin-4(3H)-one
6327-98-6

2-methylthio-3-methylpyrimidin-4(3H)-one

3-methyluracil
608-34-4

3-methyluracil

Conditions
ConditionsYield
With hydrogenchloride
With hydrogenchloride
With sodium hydroxide; water at 45 - 70℃; Kinetics;
1-methyl-2,6-dioxo-1,2,3,6-tetrahydro-pyrimidine-4-carboxylic acid
705-36-2

1-methyl-2,6-dioxo-1,2,3,6-tetrahydro-pyrimidine-4-carboxylic acid

3-methyluracil
608-34-4

3-methyluracil

Conditions
ConditionsYield
at 310℃;
With quinoline; copper
3-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid
51727-06-1

3-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid

3-methyluracil
608-34-4

3-methyluracil

Conditions
ConditionsYield
at 255℃;
1-methyl-2-methylsulfanyl-6-oxo-1,6-dihydro-pyrimidine-5-carboxylic acid
101861-31-8

1-methyl-2-methylsulfanyl-6-oxo-1,6-dihydro-pyrimidine-5-carboxylic acid

3-methyluracil
608-34-4

3-methyluracil

Conditions
ConditionsYield
With hydrogenchloride
carbonylphenyluracil
2775-86-2

carbonylphenyluracil

3-methyluracil
608-34-4

3-methyluracil

Conditions
ConditionsYield
With methylamine 1.) acetone-ether; 2.) ethanol; Yield given. Multistep reaction;
3-methyl-5,6-dihydropyrimidine-2,4(1H,3H)-dione
1672-04-4

3-methyl-5,6-dihydropyrimidine-2,4(1H,3H)-dione

3-methyluracil
608-34-4

3-methyluracil

Conditions
ConditionsYield
With dinitrogen monoxide; potassium hexacyanoferrate(III) In water at 20℃; Irradiation;
5-diazo-6-methoxy-3-methyldihydrouracil
57381-19-8

5-diazo-6-methoxy-3-methyldihydrouracil

3-methyluracil
608-34-4

3-methyluracil

Conditions
ConditionsYield
In acetonitrile at 100℃;
3-methylisouracil
95035-32-8

3-methylisouracil

3-methyluracil
608-34-4

3-methyluracil

Conditions
ConditionsYield
With dinitrogen monoxide; potassium hexacyanoferrate(III) In water at 20℃; Rate constant; Irradiation; investigation of rearrangements depending on pH;
1,6-dihydro-1-methyl-2-<2-(2-methylpropoxy)anilino>-6-dioxo-5-pyrimidinecarboxylic acid
124769-85-3

1,6-dihydro-1-methyl-2-<2-(2-methylpropoxy)anilino>-6-dioxo-5-pyrimidinecarboxylic acid

A

3-methyluracil
608-34-4

3-methyluracil

B

2-(2methylpropoxy)aniline hydrochloride
124769-90-0

2-(2methylpropoxy)aniline hydrochloride

Conditions
ConditionsYield
With hydrogenchloride In acetone for 5h; Product distribution; Heating;
sulfuric acid
7664-93-9

sulfuric acid

3-methyluridine
2140-69-4

3-methyluridine

3-methyluracil
608-34-4

3-methyluracil

Conditions
ConditionsYield
at 125℃;
3-methyl-2-ethylsulfanyl-pyrimidone-(4)

3-methyl-2-ethylsulfanyl-pyrimidone-(4)

3-methyluracil
608-34-4

3-methyluracil

Conditions
ConditionsYield
With hydrogenchloride
trans,anti-(1,3-dimethyluracil) dimer
31356-07-7, 32477-76-2

trans,anti-(1,3-dimethyluracil) dimer

A

3-methyluracil
608-34-4

3-methyluracil

B

1,3-dimethyluracil
874-14-6

1,3-dimethyluracil

C

1,3-dimethyluracil
4874-13-9

1,3-dimethyluracil

D

1,3,6-trimethyl-1H,6H-pyrido[4,3-d]pyrimidine-2,4,7-trione

1,3,6-trimethyl-1H,6H-pyrido[4,3-d]pyrimidine-2,4,7-trione

Conditions
ConditionsYield
With ammonium cerium(IV) nitrate In acetonitrile for 2h; Product distribution; Irradiation;
cis,anti-(1,3-dimethyluracil) dimer

cis,anti-(1,3-dimethyluracil) dimer

A

1-methyluracil
615-77-0

1-methyluracil

B

3-methyluracil
608-34-4

3-methyluracil

C

1,3-dimethyluracil
874-14-6

1,3-dimethyluracil

D

1,3-dimethyluracil
4874-13-9

1,3-dimethyluracil

Conditions
ConditionsYield
With ammonium cerium(IV) nitrate In acetonitrile for 2h; Product distribution; Irradiation;
2-ethoxy-3-methylpyrimidin-4-one
20541-38-2

2-ethoxy-3-methylpyrimidin-4-one

3-methyluracil
608-34-4

3-methyluracil

Conditions
ConditionsYield
With hydrogenchloride In tetrahydrofuran at 20℃; for 20h;1.65 g
3-methyluracil
608-34-4

3-methyluracil

diphenyl diselenide
1666-13-3

diphenyl diselenide

3-methyl-5-(phenylselanyl)pyrimidine-2,4(1H,3H)-dione

3-methyl-5-(phenylselanyl)pyrimidine-2,4(1H,3H)-dione

Conditions
ConditionsYield
With dihydrogen peroxide; sodium iodide In dimethyl sulfoxide at 50℃; for 3h; Schlenk technique;99%
With dihydrogen peroxide; sodium iodide In dimethyl sulfoxide at 50℃;92%
3-methyluracil
608-34-4

3-methyluracil

para-thiocresol
106-45-6

para-thiocresol

3-methyl-5-(p-tolylthio)pyrimidine-2,4(1H,3H)-dione

3-methyl-5-(p-tolylthio)pyrimidine-2,4(1H,3H)-dione

Conditions
ConditionsYield
With dihydrogen peroxide; sodium iodide In dimethyl sulfoxide at 100℃; for 18h; Schlenk technique;92%
With dihydrogen peroxide; sodium iodide In dimethyl sulfoxide at 100℃; for 15h;83%
3-methyluracil
608-34-4

3-methyluracil

diethyl sulfate
64-67-5

diethyl sulfate

1-ethyl-3-methyl-2,4-pyrimidinedione

1-ethyl-3-methyl-2,4-pyrimidinedione

Conditions
ConditionsYield
With lithium hydride In 1,4-dioxane at 60℃; for 24h; Alkylation;90%
3-methyluracil
608-34-4

3-methyluracil

benzyl tosylate
1024-41-5

benzyl tosylate

1-benzyl-3-methyl-2,4-pyrimidinedione
61686-79-1

1-benzyl-3-methyl-2,4-pyrimidinedione

Conditions
ConditionsYield
With lithium hydride In 1,4-dioxane at 60℃; for 10h; Alkylation;85%
3-methyluracil
608-34-4

3-methyluracil

Hexyl isocyanate
2525-62-4

Hexyl isocyanate

N-hexyl-3-methyl-2,4-dioxopyrimidine-1-carboxamide
1431627-93-8

N-hexyl-3-methyl-2,4-dioxopyrimidine-1-carboxamide

Conditions
ConditionsYield
Stage #1: 3-methyluracil With pyridine; dmap at 20℃; for 0.5h; Inert atmosphere;
Stage #2: Hexyl isocyanate at 20℃; for 12h; Inert atmosphere;
79%
With pyridine; dmap; triethylamine In toluene at 90℃; for 3h;
With pyridine; dmap at 60℃;
3-methyluracil
608-34-4

3-methyluracil

ethylene dibromide
106-93-4

ethylene dibromide

1-(2-bromoethyl)-3-methylpyrimidine-2,4(1H,3H)-dione

1-(2-bromoethyl)-3-methylpyrimidine-2,4(1H,3H)-dione

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 60℃; for 3h;77%
3-methyluracil
608-34-4

3-methyluracil

(1R,2R)-2-aminocyclopentan-1-ol hydrochloride
68327-11-7

(1R,2R)-2-aminocyclopentan-1-ol hydrochloride

2-((1R,2R)-2-hydroxycyclopentylamino)-3-methylpyrimidin-4(3H)-one
1228684-00-1

2-((1R,2R)-2-hydroxycyclopentylamino)-3-methylpyrimidin-4(3H)-one

Conditions
ConditionsYield
Stage #1: 3-methyluracil With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate In N,N-dimethyl-formamide at 18 - 25℃; for 0.0333333h;
Stage #2: (1R,2R)-2-aminocyclopentan-1-ol hydrochloride With 1,8-diazabicyclo[5.4.0]undec-7-ene In N,N-dimethyl-formamide at 18 - 25℃;
76%
Stage #1: 3-methyluracil With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate In N,N-dimethyl-formamide at 20℃; for 0.0333333h;
Stage #2: (1R,2R)-2-aminocyclopentan-1-ol hydrochloride With 1,8-diazabicyclo[5.4.0]undec-7-ene In N,N-dimethyl-formamide at 20℃;
76%
3-methyluracil
608-34-4

3-methyluracil

3-chloro-4-fluoronitrobenzene
350-30-1

3-chloro-4-fluoronitrobenzene

1-(2-chloro-4-nitrophenyl)-3-methyl-1H-pyrimidine-2,4-dione
1533425-47-6

1-(2-chloro-4-nitrophenyl)-3-methyl-1H-pyrimidine-2,4-dione

Conditions
ConditionsYield
With potassium tert-butylate In N,N-dimethyl-formamide at 0 - 20℃; under 760.051 Torr; Inert atmosphere;71%
3-methyluracil
608-34-4

3-methyluracil

formaldehyd
50-00-0

formaldehyd

5-(chloromethyl)-3-methyluracil
32079-00-8

5-(chloromethyl)-3-methyluracil

Conditions
ConditionsYield
With hydrogenchloride for 0.333333h; Heating;68%
3-methyluracil
608-34-4

3-methyluracil

1-formyl-5-hydroxy-3-methylhydantoin
124443-47-6

1-formyl-5-hydroxy-3-methylhydantoin

Conditions
ConditionsYield
With oxygen; ozone In acetic acid at 20℃; for 0.333333h; Product distribution;59%
With oxygen; ozone In acetic acid at 20℃; for 0.333333h;59%
3-methyluracil
608-34-4

3-methyluracil

1,10-diiododecane
16355-92-3

1,10-diiododecane

1,1'-(1,10-decanediyl)bis<3-methyluracil>

1,1'-(1,10-decanediyl)bis<3-methyluracil>

Conditions
ConditionsYield
With sodium hydride In N,N-dimethyl-formamide at 20 - 80℃; for 20h;56%
3-methyluracil
608-34-4

3-methyluracil

1,6-diiodohexane
629-09-4

1,6-diiodohexane

1,1'-(1,6-hexanediyl)bis<3-methyluracil>

1,1'-(1,6-hexanediyl)bis<3-methyluracil>

Conditions
ConditionsYield
With sodium hydride In N,N-dimethyl-formamide at 20 - 80℃; for 20h;48%
3-methyluracil
608-34-4

3-methyluracil

A

1-formyl-5-hydroxy-3-methylhydantoin
124443-47-6

1-formyl-5-hydroxy-3-methylhydantoin

B

3-methyl-5-hydroxy-imidazoline-2,4-dione
100558-37-0

3-methyl-5-hydroxy-imidazoline-2,4-dione

Conditions
ConditionsYield
With oxygen; ozone In water at 37℃; for 2h;A 44%
B 9%
1,4-Diiodobutane
628-21-7

1,4-Diiodobutane

3-methyluracil
608-34-4

3-methyluracil

1,4-bis(3-methyl-2,4-dioxo-1,2,3,4-tetrahydro-1-pyrimidinyl)butane

1,4-bis(3-methyl-2,4-dioxo-1,2,3,4-tetrahydro-1-pyrimidinyl)butane

Conditions
ConditionsYield
With sodium hydride In N,N-dimethyl-formamide at 20 - 80℃; for 20h;43%
3-methyluracil
608-34-4

3-methyluracil

1,8-diiodooctane
24772-63-2

1,8-diiodooctane

1,1'-(1,8-octanediyl)bis<3-methyluracil>

1,1'-(1,8-octanediyl)bis<3-methyluracil>

Conditions
ConditionsYield
With sodium hydride In N,N-dimethyl-formamide at 20 - 80℃; for 20h;43%
3-methyluracil
608-34-4

3-methyluracil

1,12-dibromododecane
3344-70-5

1,12-dibromododecane

1,1'-(1,12-dodecanediyl)bis<3-methyluracil>

1,1'-(1,12-dodecanediyl)bis<3-methyluracil>

Conditions
ConditionsYield
With sodium hydride In N,N-dimethyl-formamide at 20 - 80℃; for 20h;42%
3-methyluracil
608-34-4

3-methyluracil

diiodomethane
75-11-6

diiodomethane

bis(3-methyl-2,4-dioxo-1,2,3,4-tetrahydro-1-pyrimidinyl)methane

bis(3-methyl-2,4-dioxo-1,2,3,4-tetrahydro-1-pyrimidinyl)methane

Conditions
ConditionsYield
With sodium hydride In N,N-dimethyl-formamide at 20 - 80℃; for 20h;40%
3-methyluracil
608-34-4

3-methyluracil

1,3-Diiodopropane
627-31-6

1,3-Diiodopropane

1,3-bis(3-methyl-2,4-dioxo-1,2,3,4-tetrahydro-1-pyrimidinyl)propane

1,3-bis(3-methyl-2,4-dioxo-1,2,3,4-tetrahydro-1-pyrimidinyl)propane

Conditions
ConditionsYield
With sodium hydride In N,N-dimethyl-formamide at 20 - 80℃; for 20h;35%

608-34-4Relevant academic research and scientific papers

Pyrimidinedione derivative capable of inhibiting monocarboxylate transporter

-

Paragraph 0192; 0193, (2019/03/26)

The invention relates to a pyrimidinedione derivative capable of inhibiting a monocarboxylate transporter, the pyrimidinedione derivative is a formula (I) compound and/or a pharmaceutically acceptablesalt thereof, and/or a stereoisomer thereof, and/or a solvate thereof, the compound has the effect of inhibiting the activity of the monocarboxylate transporter, and also comprises a pharmaceutical composition containing the formula (I) compound and the use of the pharmaceutical composition in treatment.

Design and synthesis of uracil urea derivatives as potent and selective fatty acid amide hydrolase inhibitors

Qiu, Yan,Ren, Jie,Ke, Hongwei,Zhang, Yang,Gao, Qi,Yang, Longhe,Lu, Canzhong,Li, Yuhang

, p. 22699 - 22705 (2017/07/10)

Fatty acid amide hydrolase (FAAH) is one of the key enzymes involved in the biological degradation of endocannabinoids, especially anandamide. Pharmacological blockage of FAAH restores the levels of endocannabinoids, providing therapeutic benefits in the management of inflammation, depression and multiple sclerosis. In this study, a series of uracil urea derivatives as FAAH inhibitors were designed and synthesized. Structural modifications at the C5 position and side chain of N-hexyl-2,4-dioxo-3,4-dihydropyrimidine-1(2H)-carboxamide (1a) led to FAAH inhibitors with improved potency and selectivity. Structure-activity relationship (SAR) studies indicated that C5 electron-withdrawing substituents were preferred for optimal potency but not for selectivity, whereas replacement of the alkyl chain with phenylalkyl moieties or biphenyl groups significantly improved both inhibitory potency and selectivity towards FAAH. Two highly potent picomolar FAAH inhibitors (4c, IC50 = 0.3 ± 0.05 nM; 4d, IC50 = 0.8 ± 0.1 nM) were developed. Compound 4c inhibited FAAH in a rapid, selective, noncompetitive, and irreversible pattern. This study provides several highly potent and selective FAAH inhibitors and an optimized chemical scaffold for the development of FAAH inhibitors. We anticipate that these FAAH inhibitors will enable new possibilities in understanding FAAH functions and development of therapeutics for pain and inflammatory diseases.

Discovery of a new class of highly potent inhibitors of acid ceramidase: Synthesis and structure-activity relationship (SAR)

Pizzirani, Daniela,Pagliuca, Chiara,Realini, Natalia,Branduardi, Davide,Bottegoni, Giovanni,Mor, Marco,Bertozzi, Fabio,Scarpelli, Rita,Piomelli, Daniele,Bandiera, Tiziano

supporting information, p. 3518 - 3530 (2013/06/27)

Acid ceramidase (AC) is an intracellular cysteine amidase that catalyzes the hydrolysis of the lipid messenger ceramide. By regulating ceramide levels in cells, AC may contribute to the regulation of cancer cell proliferation and senescence and to the response to cancer therapy. We recently identified the antitumoral agent carmofur (4a) as the first nanomolar inhibitor of intracellular AC activity (rat AC, IC50 = 0.029 μM). In the present work, we expanded our initial structure-activity relationship (SAR) studies around 4a by synthesizing and testing a series of 2,4-dioxopyrimidine-1- carboxamides. Our investigations provided a first elucidation of the structural features of uracil derivatives that are critical for AC inhibition and led us to identify the first single-digit nanomolar inhibitors of this enzyme. The present results confirm that substituted 2,4-dioxopyrimidine-1-carboxamides are a novel class of potent inhibitors of AC. Selected compounds of this class may represent useful probes to further characterize the functional roles of AC.

Oxidative damage of pyrimidine nucleosides by the environmental free radical oxidant NO3? in the absence and presence of NO2? and other radical and non-radical oxidants

Goeschen, Catrin,White, Jonathan M.,Gable, Robert W.,Wille, Uta

experimental part, p. 427 - 437 (2012/08/07)

Analysis of the products formed in the reaction of the environmental free radical oxidant NO3? with permethylated uridine 1 and thymidine 2 in solution revealed highly complex reaction pathways following initial NO3? induced oxidative electron transfer at the pyrimidine ring. Product formation was found to depend not only on the nature of the nucleobase, but also on the presence of other free radical oxidants, namely NO2?. In the reaction of 1 with NO3?, which was generated through CAN photolysis, apart from formation of the highly oxidized nucleoside derivative 4 as the major product, cleavage of the CN glycosidic bond did also occur, resulting in formation of ribolactone 5 and the free nucleobase 6. The suggested mechanism involves in situ generation of NO2? during the course of the reaction, which promotes conversion of the initially formed radical cation 7 to 4 in an autocatalytic fashion.When the reaction of NO 2? with O3 was used to generate NO 3?, the initially formed radical cation 7 in the reaction with permethylated uridine 1 is rapidly trapped by NO2 ? to give 5-nitrouridine 18 in a radical mediated vinylic substitution reaction. In contrast to this, under similar conditions in the reaction involving thymidine 2 the highly oxidized products 20 and 21 are obtained as major compounds, which result from addition to the C5C6 double bond. No direct reaction between NO3? and the carbohydrate moiety in 1 and 2 was found. Also, no reaction occurred between the nucleosides and mixtures of NO2?/N2O4 and O3/O2, respectively.

PROCESS FOR STRAIGHTENING KERATIN FIBRES WITH A HEATING MEANS AND DENATURING AGENTS

-

, (2010/03/02)

The invention relates to a process for straightening keratin fibres, comprising: (i) a step in which a straightening composition containing at least two denaturing agents is applied to the keratin fibres, (ii) a step in which the temperature of the keratin fibres is raised, using a heating means, to a temperature of between 110 and 250° C.

Reactions of trimethylsilyl fluorosulfonyldifluoroacetate with purine and pyrimidine nucleosides

Rapp, Magdalena,Cai, Xiaohong,Xu, Wei,Dolbier Jr., William R.,Wnuk, Stanislaw F.

experimental part, p. 321 - 328 (2009/12/04)

Difluorocarbene, generated from trimethylsilyl fluorosulfonyldifluoroacetate (TFDA), reacts with the uridine and adenosine substrates preferentially at the enolizable amide moiety of the uracil ring and the 6-amino group of the purine ring. 2′,3′-Di-O-ben

Synthesis of uracil derivatives by oxidation of Fischer tungsten-carbene uracil complexes

Sala, Giorgio Della,Artillo, Antonietta,Ricart, Susagna,Spinella, Aldo

, p. 1623 - 1627 (2007/10/03)

A study on the oxidation of Fischer tungsten-carbene uracil complexes has been carried out. Several commonly used oxidants gave results strongly influenced by the presence of substituent on nitrogen atoms. In particular, usual oxidants failed in the oxidation of 3-alkyl uracil carbene complexes. Finally, we showed that t-butyl hydroperoxide is able to oxidize successfully also 3-alkyl uracil carbene complexes and can be used as a good alternative to the other methods.

HSAB-driven chemoselective N1-alkylation of pyrimidine bases and their 4-methoxy- or 4-acetylamino-derivatives

Gambacorta, Augusto,Tofani, Daniela,Loreto, Maria Antonietta,Gasperi, Tecla,Bernini, Roberta

, p. 6848 - 6854 (2007/10/03)

The lithium salts of the conjugated bases of 4-methoxy- and 4-acetylamino-2(1H)-pyrimidinones 1-3 undergo highly chemoselective N1-methylation or ethylation when treated with methyl- or ethylsulfate (hard electrophiles) in dry dioxane, while the use of DMF as solvent results in competitive O2-alkylation. Potassium salts of the same bases in DMF undergo prevalent O2-attack. Under the same conditions, a similar but less chemoselective behaviour is observed in alkylation of thymine and uracil, where some N3-attack occurs. This can be rationalised in terms of the HSAB principle.

Synthesis and pharmacology of willardiine derivatives acting as antagonists of kainate receptors

Dolman, Nigel P.,Troop, Helen M.,More, Julia C. A.,Alt, Andrew,Knauss, Jody L.,Nistico, Robert,Jack, Samantha,Morley, Richard M.,Bortolotto, Zuner A.,Roberts, Peter J.,Bleakman, David,Collingridge, Graham L.,Jane, David E.

, p. 7867 - 7881 (2007/10/03)

The natural product willardiine (8) is an AMPA receptor agonist while 5-iodowillardiine (10) is a selective kainate receptor agonist. In an attempt to produce antagonists of kainate and AMPA receptors analogues of willardiine with substituents at the N3 position of the uracil ring were synthesized. The N3-4-carboxybenzyl substituted analogue (38c) was found to be equipotent at AMPA and GLUK5-containing kainate receptors in the neonatal rat spinal cord. The N3-2-carboxybenzyl substituted analogue (38a) proved to be a potent and selective GLUK5 subunit containing kainate receptor antagonist when tested on native rat and human recombinant AMPA and kainate receptor subtypes. The GLUK5 kainate receptor antagonist activity was found to reside in the S enantiomer (44a) whereas the R enantiomer (44b) was almost inactive. 5-Iodo substitution of the uracil ring of 44a gave 45, which was found to have enhanced potency and selectivity for GLU K5.

Effect of the structure of 1- and 3-methylpyrimidin-4-ones on the rate of nucleophilic substitution of the 2-methylsylfanyl group

Kheifets,Gindin,Nikolova

, p. 104 - 113 (2007/10/03)

Rate constants for substitution of the 2-methylsulfanyl group in 1- and 3-methyl-2-methylsulfanyl-pyrimidin-4-ones and their 5-fluoro analogs were measured in the reaction with butylamine, alkaline hydrolysis, and methanolysis. The rate of substitution in 1-methyl isomers having a zwitterionic structure is greater by a factor of ~2 than the rate of substitution in 3-methyl isomers with conjugated double bonds in the ring. The presence of a fluorine atom in position 5 accelerates nucleophilic substitution in 1-methyl isomers, while 5-fluoro-3-methyl-2-methylsulfanylpyrimidin-4-ones react at a lower rate than their 5-unsubstituted analogs. According to the NMR data, the reactions involve formation of a tetrahedral intermediate. Anchimeric effect of the methyl group on N1 hampers attack by basic reagent on the C6 atom.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 608-34-4